Category: Gene Therapy
Gene Therapy market research reports by GlobalData
-
Gene therapy - Lipid nanoparticles
Gene therapy - Lipid nanoparticles Summary Gene Therapy: Lipid nanoparticles is part of GlobalData's Analyst opinions series. Gene therapy sales are projected to exced $10bn by 2027 and lipid nanoparticles (LNPs) have gained popularity as carriers for gene therapies due to their high tolerance, low ... Read More
-
4D Molecular Therapeutics Inc (FDMT) - Financial and Strategic SWOT Analysis Review
4D Molecular Therapeutics Inc (FDMT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a ... Read More
-
Cell and Gene Therapies in Ophthalmology
Cell and Gene Therapies in Ophthalmology Summary Currently, there are eight cell and gene therapies (CGTs) on the market for various ophthalmology indications. These comprise Spark Therapeutics' Luxturna (voretigene neparvovec), which is indicated for retinitis pigmentosa (retinitis) and Leber conge ... Read More
-
Cell and Gene Therapies in CNS Disorders
Cell and Gene Therapies in CNS Disorders Summary Currently, there are eight cell and gene therapies (CGT) on the market for various central nervous system (CNS) disorders. This includes three gene therapies, two gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’ ... Read More
-
Cell and Gene Therapies in Hemophilia A & B
Cell and Gene Therapies in Hemophilia A & B Summary Clients will gain insight into the competitive landscape of leading CGT agents in Hemophilia A & B including launch date projections, key clinical trial analysis, analyst consensus forecasts, likelihood of approval analysis, and commentary on curre ... Read More
-
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More
-
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More
-
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-b ... Read More
-
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027 Summary The gene therapy in oncology market size ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
Research Assistance
